RESUMO
Despite the rapid growth in popularity of the Jersey breed, most research on dairy cows in the United States has been done with the Holstein breed. Postpartum uterine diseases negatively influence reproductive performance of dairy cows and limited data are available regarding predisposing factors for uterine diseases in Jersey cows. Our objectives were to determine the prevalence and risk factors for purulent vaginal discharge (PVD) and its effect on fertility of lactating Jersey cows. This was a retrospective observational study with data collected from 3,822 Jersey cows. The Metricheck device was used for PVD diagnosis, and positive cases (≥50% of pus in exudate) were further classified for severity using the following 4 categories based on the amount of pus observed: 50 to 60% pus in exudate, 60 to 90% pus in exudate, 90 to 100% pus in exudate, and 90 to 100% pus in exudate + uterine fluid detected by palpation per rectum. Univariable and multivariable regression analyzes were conducted to dissect the risk factors for PVD and severity of PVD in Jerseys cows. The major risk factors for PVD were calving-related problems, retained fetal membrane, metritis, and days in the close-up diet. A subgroup of cows (n = 740) was scored for body condition and locomotion scores and had blood sampled in the peripartum for determination of plasma concentrations of nonesterified fatty acids and ß-hydroxybutyrate. In the multivariable analysis that considered data collected for the subgroup of cows, peripartum nonesterified fatty acids, postpartum ß-hydroxybutyrate, and peripartum locomotion and body condition scores were not retained in the reduced model of predictors of PVD. Not surprisingly, pregnancy per artificial insemination following the first and second services was reduced in cows diagnosed with PVD compared with cows without PVD. In addition, PVD was associated with increased odds of pregnancy loss after the first service and reduced hazard of pregnancy by 305 d in milk. The stratification of PVD severity according to the amount of pus observed and the consistency of the uterus was meaningful, as observed by the differences in reproductive outcomes between cows with diverging amounts of pus in the retrieved exudate. Risk factors for PVD in Jersey cows was similar to previously reported for Holstein cows, and a strong detrimental effect of PVD on fertility was also observed in Jersey cows.
Assuntos
Doenças dos Bovinos , Descarga Vaginal , Animais , Bovinos , Doenças dos Bovinos/epidemiologia , Feminino , Lactação , Gravidez , Reprodução , Fatores de Risco , Descarga Vaginal/veterináriaRESUMO
Objectives of the current experiment were to evaluate the effects of treatment of periparturient dairy cows with recombinant bovine somatotropin (rbST) on mRNA expression in peripheral leukocytes for genes related to the somatotropic axis, cell energy metabolism, and innate and adaptive immune responses. Cows were enrolled in the experiment at 253 ± 3 d of gestation and assigned to an untreated control group (n = 98) or to receive 125 mg of rbST weekly from -21 to 21 d relative to calving (rbST125; n = 98). Data from a subsample of cows (control = 16, rbST125 = 16) are reported herein. Hemogram and polymorphonuclear leukocyte (PMNL) phagocytosis, oxidative burst, and expression of adhesion molecules were determined weekly, from -28 ± 3 to 24 ± 3 d relative to calving. Cows were vaccinated with ovalbumin at -21 ± 3, -7 ± 3, and 7 ± 3 d relative to calving. Serum IgG anti-ovalbumin and haptoglobin optical densities were determined weekly, from -28 ± 3 to 24 ± 3 d relative to calving. Leukocytes were isolated from whole blood on d -21 ± 3, -7 ± 3, and 7 ± 3 relative to calving to determine leukocyte mRNA expression for 66 genes. Cows in the rbST125 treatment had greater concentration of granulocytes 1 wk prepartum (control = 3.7 ± 0.4 vs. rbST125 = 4.6 ± 0.4 × 109 cells/L). Expression of CD18 by PMNL during the prepartum (control = 3,262 ± 280 vs. rbST125 = 3,926 ± 260 geometric mean fluorescence intensity) and percentage of PMNL positive for phagocytosis and oxidative burst 1 wk postpartum (control = 59.2 ± 2.8 vs. rbST125 = 67.6 ± 3.1%) were increased in rbST125 cows. Postpartum IgG anti-ovalbumin optical density was higher in rbST125 cows than control cows (control = 1.5 ± 0.1 vs. rbST125 = 1.9 ± 0.1 optical density). On d -7 relative to calving, leukocyte mRNA expression of IGF1R and JAK1 tended to be downregulated and expression of DEFB3 tended to be upregulated by rbST treatment. Expression of mRNA for STAT1, RELA, and NOD2 tended to be upregulated, expression of RAC2 was downregulated, and expression of JAK3, BLK, and TNFα tended to be downregulated on d 7 relative to calving by rbST treatment. Effects of treatment of periparturient cows with 125 mg of rbST on leukocyte gene expression were minute; thus, additional experiments are necessary to elucidate how rbST-induced increases in growth hormone and insulin-like growth factor-1 concentrations may modulate the immune response of periparturient cows.
Assuntos
Hormônio do Crescimento/farmacologia , Leucócitos/efeitos dos fármacos , RNA Mensageiro/metabolismo , Imunidade Adaptativa/genética , Animais , Bovinos , Citocinas/biossíntese , Metabolismo Energético/genética , Feminino , Lactação , Leucócitos/metabolismo , Fagocitose/genética , Proteínas Recombinantes/farmacologia , Explosão Respiratória/genéticaRESUMO
Objectives of this experiment were to evaluate the effects of recombinant bovine somatotropin (rbST) treatment of periparturient dairy cows on hepatic mRNA expression for genes related to the somatotropic axis, insulin, glucose, and lipid metabolism, inflammation, and oxidative stress. Holstein cows were enrolled in the experiment at 253 ± 3 d of gestation and assigned to 1 of 3 treatments: untreated control (n = 53), 87.5 mg of rbST (n = 56; rbST87.5), and 125 mg of rbST (n = 57; rbST125). Cows in the rbST87.5 and rbST125 treatments received weekly injections of rbST from -21 to 28 d relative to calving. A subsample of cows (control = 20, rbST87.5 = 20, rbST125 = 20) was randomly selected for collection of liver samples according to expected calving date, BCS, and previous lactation 305-d mature equivalent milk yield. Only cows that had liver sampled at -21 ± 3, -7 ± 3, and 7 ± 3 d relative to calving were used in the current experiment. Blood, sampled weekly from -28 to 21 d relative to calving, was used to determine the concentrations of growth hormone, insulin-like growth factor 1, insulin, cortisol, fatty acids, ß-hydroxybutyrate, glucose, haptoglobin, and tumor necrosis factor-α. Liver samples were used to determine hepatic mRNA expression of 50 genes. Treatment with rbST increased growth hormone concentrations during the postpartum period (control = 9.0 ± 0.7, rbST87.5 = 15.3 ± 1.0, rbST125 = 18.5 ± 1.3 ng/mL) and increased insulin-like growth factor 1 concentrations during the prepartum period (control = 107.4 ± 7.2, rbST87.5 = 126.9 ± 6.6, rbST125 = 139.4 ± 6.9 ng/mL). Control cows had greater postpartum concentrations of ß-hydroxybutyrate (control = 776.4 ± 64.0, rbST87.5 = 628.4 ± 59.7, rbST125 = 595.4 ± 60.9 µmol/L) than rbST cows. The rbST87.5 and rbST125 treatments upregulated the hepatic mRNA expression for somatotropic axis genes (GHR, GHR1A, IGF1, IGFBP3, and SOCS2) on d -7 relative to calving and upregulated the mRNA expression for SOCS2 on d 7. On d -7, rbST87.5 and rbST125 treatments increased mRNA expression for genes involved in hepatic lipid transport (ANGPTL4, APOA5, APOB100, and SCARB1) and downregulated mRNA expression for PPARD, which is involved in lipid storage. On d 7, rbST tended to upregulate the mRNA expression for genes involved in gluconeogenesis (PCK1) and fatty acid ß-oxidation (ACOX1), and downregulated the mRNA expression for genes involved in inflammation (TNFRSF1A, ICAM1, CXCL1, MYD88, HIF1A, IL1RN, NFKBIA, and SOCS3) and oxidative stress (XBP1). Administration of rbST during the periparturient period may improve liver function and health by increasing hepatic capacity for gluconeogenesis and lipid transport and by reducing inflammation and oxidative stress.
Assuntos
Glucose/metabolismo , Hormônio do Crescimento/sangue , Animais , Bovinos , Ácidos Graxos não Esterificados/sangue , Feminino , Lactação , Metabolismo dos Lipídeos , Fígado/metabolismo , Leite/metabolismo , RNA Mensageiro/metabolismoRESUMO
The objectives of the current experiment were to evaluate the effects of treating periparturient dairy cows with recombinant bovine somatotropin (rbST) on incidence of postpartum diseases and performance. Holstein (HO) and Jersey (JS) cows from 2 herds were enrolled in the experiment at 253 ± 3 d of gestation and assigned to the control (n = 432) and rbST125 (n = 437) treatments. Cows in the rbST125 treatment received 125 mg of rbST, weekly, from -21 to 21 d relative to calving. Blood sampled weekly, from -21 to 21 d relative to calving, from a subsample of cows was used to determine the concentrations of growth hormone (GH, HO = 106) and insulin-like growth factor 1 (IGF-1, HO = 147 and JS = 49). Cows were scored for body condition (BCS) at enrollment and at 1 ± 3, 30 ± 3, and 60 ± 3 d in milk (DIM). Cows were milked thrice daily and energy-corrected milk (ECM) yield was recorded for the first 30 DIM. Treatment of cows with rbST resulted in greater concentrations of GH during the prepartum (log10 back-transformed concentrations of GH: HO-control = 7.83 and HO-rbST125 = 10.36 ng/mL) and postpartum (log10 back-transformed concentrations of GH: HO-control = 10.45 and HO-rbST125 = 18.47 ng/mL) periods. Similarly, IGF-1 concentrations were higher during the prepartum (HO-control = 115.1 ± 4.9, HO-rbST125 = 137.7 ± 4.7, JS-control = 120.2 ± 8.3, JS-rbST125 = 167.1 ± 8.1 ng/mL) and postpartum (HO-control = 61.3 ± 4.0, HO-rbST125 = 75.2 ± 3.8, JS-control = 35.5 ± 6.9, JS-rbST125 = 54.6 ± 6.9 ng/mL) periods for rbST-treated cows. During the prepartum period, BCS was not affected by treatment, but during the postpartum period, BCS was reduced for rbST-treated cows (HO-control = 3.00 ± 0.03, HO-rbST125 = 2.90 ± 0.03, JS-control = 2.64 ± 0.02, JS-rbST125 = 2.61 ± 0.02). Cows from the rbST125 treatment tended to have lower incidence of retained fetal membranes (HO-control = 14.3, HO-rbST125 = 6.1, JS-control = 1.5, JS-rbST125 = 1.2%) and had reduced incidence of metritis (HO-control = 26.2, HO-rbST125 = 16.6, JS-control = 19.9, JS-rbST125 = 13.3%) compared with control cows. Ketosis incidence tended to be higher for rbST125 cows (HO-control = 9.4, HO-rbST125 = 11.3, JS-control = 8.5, JS-rbST125 = 13.4%) compared with control cows. The interaction between treatment and herd tended to affect yield of ECM during the first 30 DIM because HO cows treated with rbST during the periparturient period had greater yield than control HO cows (HO-control = 35.5 ± 1.0 vs. HO-rbST125 = 39.4 ± 1.0 kg/d), but treatment with rbST did not affect yield of ECM of JS cows (JS-control = 26.7 ± 0.6 vs. JS-rbST125 = 27.8 ± 0.6 kg/d). Treatment of periparturient dairy cows with 125 mg of rbST decreased the incidence of uterine disorders in HO and JS cows and increased yield of ECM during the first 30 DIM among HO cows, despite slightly increasing the incidence of ketosis.
Assuntos
Hormônio do Crescimento/farmacologia , Lactação/efeitos dos fármacos , Animais , Bovinos , Doenças dos Bovinos/epidemiologia , Ácidos Graxos não Esterificados/sangue , Feminino , Hormônio do Crescimento/sangue , Leite/metabolismo , Período Pós-Parto , ReproduçãoRESUMO
The objectives of this study were to determine the effects of prepartum stocking density on social, lying, and feeding behavior of dairy animals and to investigate the relationship between social rank and stocking density. In total, 756 Jersey animals were enrolled in the study approximately 4 wk before expected calving date. This study used 8 experimental units (4 replicates × 2 pens/treatment per replicate), and at each replicate, one pen each of nulliparous and parous (primiparous and multiparous) animals per treatment was enrolled. The 2 treatments were 80% stocking density (80D, 38 animals per pen; each pen with 48 headlocks and 44 stalls) and 100% stocking density (100D, 48 animals per pen). Parous animals were housed separately from nulliparous animals. Animals at 254±3d of gestation were balanced for parity (parous vs. nulliparous) and projected 305-d mature-equivalent milk yield (only parous animals) and randomly assigned to either 80D or 100D. Displacements from the feed bunk were measured for 3h after fresh feed delivery on d 2, 5, and 7 of each week. Feeding behavior was measured for 24-h periods (using 10-min video scan sampling) on d 2, 5, and 7 on wk 1 of every replicate and d 2 and 5 for the following 4 wk. A displacement index (proportion of successful displacements from the feed bunk relative to all displacements the animal was involved in) was calculated for each animal and used to categorize animals into ranking categories of high, middle, and low. Seventy nulliparous and 64 parous focal animals in the 80D treatment and 89 nulliparous and 74 parous focal animals in the 100D were used to describe lying behavior (measured with data loggers). Animals housed at 80D had fewer daily displacements from the feed bunk than those housed at 100D (15.2±1.0 vs. 21.3±1.0 per day). Daily feeding times differed between nulliparous and parous animals at the 2 stocking densities. Nulliparous 80D animals spent 12.4±5.0 fewer minutes per day feeding than nulliparous 100D animals, whereas 100D parous animals tended to spend 7.6±4.5 fewer minutes per day feeding than 80D parous animals. The 2 treatments were not different in the number of lying bouts or lying-bout duration; lying time was longer for 100D on d -33, -29, and -26 and shorter on d -7, -5, and 0 than 80D. The interaction between treatment, parity, and social rank was associated with lying and feeding times. In summary, animals in the 80D treatment had a lower number of displacements from the feed bunk and spent more time lying down near parturition than 100D animals, and 80D nulliparous animals had reduced daily feeding time compared with 100D nulliparous animals. Although these results showed some potential behavior benefits of a prepartum stocking density of 80% compared with 100%, observed changes were small. However, greater stocking density cannot be recommended; more research is needed to evaluate the effects of stocking densities greater than 100% and with other breeds of cattle besides Jersey.
Assuntos
Comportamento Animal , Bovinos/fisiologia , Indústria de Laticínios/métodos , Leite/metabolismo , Animais , Comportamento Alimentar , Feminino , Paridade/fisiologia , Densidade Demográfica , Gravidez , Comportamento SocialRESUMO
The aim of this experiment was to determine effects of treating peripartum dairy cows with body condition score ≥3.75 with recombinant bovine somatotropin (rbST) on immune, inflammatory, and metabolic responses. Holstein cows (253±1d of gestation) were assigned randomly to 1 of 3 treatments: untreated control (n=53), rbST87.5 (n=56; 87.5mg of rbST), and rbST125 (n=57; 125mg of rbST). Cows in the rbST87.5 and rbST125 treatments received rbST weekly from -21 to 28d relative to calving. Growth hormone, insulin-like growth factor 1, haptoglobin, tumor necrosis factor α, nonesterified fatty acids, ß-hydroxybutyrate, glucose, and cortisol concentrations were determined weekly from -21 to 21d relative to calving. Blood sampled weekly from -14 to 21d relative to calving was used for hemogram and polymorphonuclear leukocyte (PMNL) expression of adhesion molecules, phagocytosis, and oxidative burst. Cows were vaccinated with ovalbumin at -21, -7, and 7d relative to calving, and blood was collected weekly from -21 to 21d relative to calving to determine IgG anti-ovalbumin concentrations. A subsample of cows had liver biopsied -21, -7, and 7d relative to calving to determine total lipids, triglycerides, and glycogen content. Growth hormone concentrations prepartum (control=11.0±1.2, rbST87.5=14.1±1.2, rbST125=15.1±1.3ng/mL) and postpartum (control=14.4±1.1, rbST87.5=17.8±1.2, rbST125=21.8±1.1ng/mL) were highest for rbST125 cows. Cows treated with rbST had higher insulin-like growth factor 1 concentrations than control cows (control=110.5±4.5, rbST87.5=126.2±4.5, rbST125=127.2±4.5ng/mL) only prepartum. Intensity of L-selectin expression was higher for rbST125 than for control and rbST87.5 cows [control=3,590±270, rbST87.5=3,279±271, rbST125=4,371±279 geometric mean fluorescence intensity (GMFI)] in the prepartum period. The PMNL intensities of phagocytosis (control=3,131±130, rbST87.5=3,391±133, rbST125=3,673±137 GMFI) and oxidative burst (control=9,588±746, rbST87.5=11,238±761, rbST125=12,724±781 GMFI) were higher for rbST125 cows than for control cows during the prepartum period. Concentrations of serum IgG anti-ovalbumin tended to be higher for rbST125 cows than for control cows (control=0.75±0.11, rbST87.5=0.94±0.10, rbST125=1.11±0.11 optical density) in the prepartum period. Haptoglobin concentration was significantly reduced 7d postpartum for rbST125 treatment compared with control and rbST87.5 treatments (control=2.74±0.28, rbST87.5=2.81±0.28, rbST125=1.87±0.28 optical density). Although treatment tended to affect postpartum ß-hydroxybutyrate (control=747.5±40.2, rbST87.5=753.2±40.1, rbST125=648.8±39.7 µmol/L), it did not affect liver contents of total lipids, triglycerides, or glycogen. Incidence of metritis among rbST125 cows was reduced compared with that in control cows (control=23.1, rbST87.5=18.0, rbST125=7.8%). Treatment of dairy cows with 125mg of rbST improved innate immune responses and IgG concentration, with limited effects on metabolism.
Assuntos
Doenças dos Bovinos/fisiopatologia , Hormônio do Crescimento/administração & dosagem , Inflamação/veterinária , Período Periparto , Período Pós-Parto , Ácido 3-Hidroxibutírico/sangue , Imunidade Adaptativa/imunologia , Animais , Bovinos , Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/imunologia , Doenças dos Bovinos/metabolismo , Ácidos Graxos não Esterificados/sangue , Feminino , Hormônio do Crescimento/sangue , Haptoglobinas/análise , Inflamação/imunologia , Inflamação/metabolismo , Fator de Crescimento Insulin-Like I/metabolismo , Selectina L/metabolismo , Neutrófilos/imunologia , Ovalbumina/imunologia , Período Periparto/fisiologia , Fagocitose/imunologia , Período Pós-Parto/imunologia , Explosão Respiratória/imunologiaRESUMO
The objective of the current study was to determine whether providing stable pen management affected displacements from the feed bunk and feeding behavior of prepartum dairy cows. Two hundred and twenty-four nonlactating Jersey primiparous and multiparous cows were enrolled in the study. The 2 treatments were all-in-all-out (AIAO; 44 cows were moved into the close-up prepartum pen as 1 group, with no additions during the 5-wk repetition) or traditional (TRD; with weekly entrance of new cows to maintain a pen density of 44 cows). Cows (253 ± 3 d of gestation) were balanced for parity and projected 305-d mature-equivalent milk yield and assigned randomly to either AIAO or TRD treatments. At enrollment, cows with a body condition score <2 or >4 (1-5 scale; 1 = emaciated and 5 = obese) or with a locomotion score >3 (1-5 scale; 1 = normal gait and 5 = severely lame) were not included. Displacements from the feed bunk were measured weekly for both treatments when TRD cows were moved into the close-up pen (d 0) and additionally on d 1, 2, 3, and 7 for 3h after fresh feed delivery. A displacement rate was created to take into account differences in stocking density throughout the experiment. Displacement rate was calculated as the number of displacements divided by the number of cows in the pen at that time. Feeding behavior was measured using video 10-min scan sampling for 24-h periods at d 0, 1, 2, and 7. Displacements and feeding behavior were recorded for all 5 wk of each repetition. Treatment × week interactions were detected for number of displacements and displacement rate. The TRD treatment had more displacements from the feed bunk than AIAO in wk 1, 3, and 5, with no differences in wk 2 and 4. Similarly, the TRD treatment had a greater displacement rate than the AIAO treatment in wk 1 and 5, with a tendency in wk 3. No differences between the treatments were detected in wk 2 and 4. A treatment × week interaction existed for feeding time. Cows housed in the AIAO treatment had longer average feeding times in wk 2 with a tendency in wk 3, but spent 39 fewer minutes eating than those in the TRD treatment during the wk 1 of the study. Housing prepartum close-up cows with stable pen management reduced displacements from the feed bunk and altered average daily feeding times.
Assuntos
Comportamento Animal , Bovinos/fisiologia , Comportamento Alimentar , Animais , Indústria de Laticínios , Feminino , Lactação , Leite/metabolismo , Paridade , Gravidez , Distribuição Aleatória , Fatores de TempoRESUMO
The objectives of this study were to evaluate effects of 2 resynchronization protocols beginning at different intervals after artificial insemination (AI) on the pattern of return to estrus, ovarian responses, and pregnancy per AI (P/AI) to reinsemination. Lactating cows from 2 dairies, located in Texas (n=2,233) and Minnesota (n=3,077), were assigned to 1 of 4 timed AI (TAI) protocols 17 ± 3 d after AI. All cows were examined for pregnancy 31 ± 3 d after previous AI. Cows assigned to early Ovsynch56 (E-OV56) or OV56 received the Ovsynch56 protocol starting 24 or 31 d after AI, respectively. Cows assigned to early GnRH-GnRH-PGF(2α)-GnRH (E-GGPG) or GGPG received a presynchronizing GnRH injection 17 or 24 d after AI, respectively, 7 d before the start of the Ovsynch56 protocol. Cows observed in estrus after enrollment were inseminated on the same day. Ovaries were examined and blood was sampled for progesterone concentration on the day of first GnRH and PGF(2α) injection of the Ovsynch56 protocol. Pregnancy was diagnosed at 31 and 66 d after resynchronized AI. On the day of the first GnRH injection of the TAI, a higher percentage of cows on E-GGPG and GGPG protocols had a corpus luteum (E-GGPG=83.8, GGPG=91.2, E-OV56=80.4, and OV56=75.5%) and progesterone concentration >1 ng/mL (E-GGPG=62.5, GGPG=76.0, E-OV56=53.6, and OV56=60.8%) than cows assigned to other protocols. However, the percentage of cows ovulating to the first GnRH injection of TAI was not affected by treatment. Fewer E-GGPG and more OV56 cows were reinseminated in estrus (E-GGPG=23.7, GGPG=49.0, E-OV56=41.6, and OV56=57.6%). Treatment did not affect P/AI at 31 or 66 d for cows reinseminated in estrus. However, cows reinseminated in estrus had greater P/AI at 31 (40.0 vs. 27.5%) and 66 d (36.0 vs. 23.9%) than cows completing the TAI protocols. Among cows completing the TAI protocols, initiation of GGPG at 24 d after AI increased, whereas initiation of Ovsynch56 at 24 d after AI decreased P/AI at 31 d after reinsemination (E-GGPG=30.6, GGPG=28.3.0, E-OV56=22.3, and OV56=28.7%). Pregnancy per AI did not differ across treatment at 66 d after TAI (E-GGPG=26.6, GGPG=24.4, E-OV56=20.0, and OV56=24.1%). Overall, type of resynchronization protocol and protocol initiation time did not affect P/AI 66 d after reinsemination (E-GGPG=29.7, GGPG=30.5, E-OV56=26.1, and OV56=30.4%). In conclusion, GGPG resynchronization protocols and initiation of resynchronization protocol 24 d after AI reduced the number of cows reinseminated in estrus but neither the timing of initiation of resynchronization nor presynchronization with GnRH affected overall P/AI.
Assuntos
Sincronização do Estro/métodos , Fertilidade/efeitos dos fármacos , Hormônio Liberador de Gonadotropina/farmacologia , Injeções/métodos , Lactação/efeitos dos fármacos , Animais , Bovinos , Corpo Lúteo/efeitos dos fármacos , Dieta/veterinária , Estro/efeitos dos fármacos , Sincronização do Estro/efeitos dos fármacos , Feminino , Fertilidade/fisiologia , Inseminação Artificial/veterinária , Lactação/fisiologia , Modelos Logísticos , Minnesota , Ovário/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Ovulação/fisiologia , Gravidez , Progesterona/sangue , TexasRESUMO
The objectives of the current experiment were to determine the effects of 2 prepartum stocking densities on milk yield, concentration of metabolites during the peripartum period, and health and reproductive parameters of dairy cows. Jersey cows enrolled in the experiment at 254±3 d of gestation were balanced for parity (nulliparous vs. parous) and previous lactation projected 305-d mature equivalent milk yield (parous) and assigned to 1 of 2 treatments: 80% headlock stocking density (80SD; 38 animals/48 headlocks) and 100% headlock stocking density (100SD; 48 animals/48 headlocks). The number of experimental units was 8 (4 replicates and 2 pens/treatment per replicate). In total, 154 nulliparous and 184 parous animals were enrolled in the 80SD treatment and 186 nulliparous and 232 parous animals were enrolled in the 100SD treatment. At the start of each replicate, treatments were switched within pen. Cows were milked thrice daily and monthly milk yield, fat and protein content, and somatic cell count data were recorded up to 155 d postpartum. Plasma nonesterified fatty acid concentration was measured weekly, from -18±3 to 17±3 d relative to calving, and plasma ß-hydroxybutyrate was measured weekly, from 1±2 to 17±3 d relative to calving. Cows were examined 1, 4±1, 7±1, 10±1, and 13±1 d relative to calving for diagnosis of uterine diseases. Blood was sampled for determination of progesterone concentration and resumption of ovarian cycles 35±3 and 45±3 d relative to calving. Average headlock (74.1±0.4 vs. 94.5±0.3%) and stall (80.8±0.4 vs. 103.1±0.4%) stocking density was lower for the 80SD treatment compared with the 100SD treatment. Treatment did not affect incidence of retained fetal membranes (80SD=5.1, 100SD=7.8%), metritis (80SD=21.2, 100SD=16.7%), acute metritis (80SD=9.9, 100SD=9.4%), and vaginal purulent discharge (80SD=5.8, 100SD=7.9%). Concentrations of nonesterified fatty acids (80SD=251.5±6.1, 100SD=245.9±5.6µmol/L) and ß-hydroxybutyrate (80SD=508.2±14.3, 100SD=490.9±13.6µmol/L) were not different between treatments. Treatment had no effect on percentage of cows removed from the herd on the first 60 d postpartum (80SD=6.1, 100SD=5.1%) and on rate of removal from the herd up to 305 d postpartum 80SD=referent, 100SD [adjusted hazard ratio (95% confidence interval)]=1.02 (0.75, 1.38). Percentages of cows pregnant to first (80SD=41.9, 100SD=48.4%) and second (80SD=49.3, 100SD=42.0%) postpartum AI were not different between treatments. Finally, treatment did not affect energy-corrected milk yield up to 155 d postpartum (80SD=33.8±0.5, 100SD=33.4±0.5kg/d). In herds with weekly or twice weekly movement of new cows to the prepartum pen and separate housing of nulliparous and parous animals, a target stocking density of 100% of headlocks on the day of movement is not expected to affect health, metabolic, reproductive, and productive parameters.
Assuntos
Doenças dos Bovinos/epidemiologia , Bovinos/fisiologia , Endometrite/veterinária , Leite/metabolismo , Placenta Retida/veterinária , Reprodução , Ácido 3-Hidroxibutírico/sangue , Animais , Comportamento Animal , Contagem de Células , Endometrite/epidemiologia , Ácidos Graxos não Esterificados/sangue , Feminino , Incidência , Lactação , Modelos Logísticos , Paridade , Período Periparto , Placenta Retida/epidemiologia , Densidade Demográfica , Período Pós-Parto , Gravidez , Progesterona/sangueRESUMO
The objectives of this experiment were to determine the speed at which cows that had their estrous cycle presynchronized with a GnRH or PGF(2α) injection are reinseminated and become pregnant. Furthermore, this experiment aimed to determine whether treatment with a controlled internal drug-releasing (CIDR) insert during the timed artificial insemination (AI) protocol improves pregnancy per AI (P/AI) of cows that had their estrous cycle presynchronized with GnRH or PGF(2α). Lactating cows from 2 herds were assigned to 1 of 2 presynchronization treatments at 32 ± 4 d after AI: GGPG (n=452)--GnRH injection at enrollment (d 0), 7d before the start of the timed AI protocol, and P11GPG (n=466)--PGF(2α) injection on d 3, 11 d before the start of the timed AI protocol. Cows observed in estrus at any interval after enrollment were reinseminated on the same day. Cows not observed in estrus by d 7 were paired by presynchronization treatment and assigned to receive or not receive a CIDR insert during the timed AI protocol (CIDR = 240, no CIDR = 317). Timed AI protocols were the Ovsynch56 at site A and the Cosynch48 at site B. A subsample of cows from site A had their ovaries scanned by ultrasound at enrollment and on the day of the first GnRH and PGF(2α) injections of the timed AI protocol and had blood sampled at each injection of the timed AI protocol for determination of progesterone concentration. Cows were examined for pregnancy 32 ± 4 and 67 ± 4 d after reinsemination. Cows in the P11GPG treatment had a faster reinsemination rate [adjusted hazard ratio = 1.24 (95% CI = 1.07, 1.45)] and were less likely to be submitted to the timed AI protocol (40.3 vs. 89.8%) and to be reinseminated at a fixed time (38.6 vs. 83.9%). The interval from enrollment to reinsemination was shorter for cows in the P11GPG group (13.0 ± 0.4 vs. 15.0 ± 0.2d). Presynchronization treatment did not affect P/AI 32 ± 4 d (GGPG = 42.3%, P11GPG = 39.3%) and 67 ± 4 d (GGPG = 37.0%, P11GPG = 35.4%) after reinsemination. Pregnancy rate from d 0 to 7 (GGPG = 3.6%, P11GPG = 17.7%) and from d 8 to 14 (GGPG = 1.6%, P11GPG = 5.7%) were greater for cows in the P11GPG treatment. Treatment with the CIDR insert during the timed AI protocol did not affect P/AI 32 ± 4 d (CIDR = 41.7%, no CIDR = 41.4%) and 67 ± 4 d (CIDR = 36.5%, no CIDR = 35.3%) after reinsemination. A greater percentage of cows in the GGPG treatment had progesterone concentration ≥ 1 ng/mL on the day of the first GnRH injection of the timed AI protocol (83.8 vs. 51.5%), but a greater percentage of cows in the P11GPG treatment ovulated in response to the first GnRH injection of the timed AI protocol (66.1 vs. 46.8%). We conclude that the P/AI of cows that had their estrous cycle presynchronized with GnRH or PGF(2α) was not different, but in herds with adequate estrous detection efficiency and accuracy, presynchronization with PGF(2α) may reduce the interval to the establishment of pregnancy.
Assuntos
Sincronização do Estro/métodos , Animais , Bovinos , Dinoprosta/administração & dosagem , Dinoprosta/farmacologia , Implantes de Medicamento , Ciclo Estral/efeitos dos fármacos , Ciclo Estral/fisiologia , Feminino , Hormônio Liberador de Gonadotropina/administração & dosagem , Hormônio Liberador de Gonadotropina/farmacologia , Inseminação Artificial/métodos , Inseminação Artificial/veterinária , Lactação/efeitos dos fármacos , Lactação/fisiologia , Gravidez , Fatores de TempoRESUMO
The objectives of the current experiment were to evaluate the reproductive performance and economic outcome of 3 synchronization strategies for first artificial insemination (AI) of dairy heifers. Holstein heifers from 2 herds (site A, California, n=415; site B, Idaho, n=425) were assigned to 1 of 3 treatments. Heifers assigned to the AI on estrus (AIE) treatment received an injection of 25mg of PGF(2α) at enrollment (d 0) and every 11 d thereafter until AI occurred. Heifers assigned to the CIDR5 treatment received a controlled internal drug release insert (CIDR) containing 1.38 g of progesterone, which was removed 5 d later concomitantly with an injection of 25mg of PGF(2α), and received fixed-time AI (TAI) concomitantly with an injection of 100 µg of GnRH 53 to 60 h later. Heifers assigned to the CIDR7 treatment received a CIDR insert, which was removed 7 d later concomitantly with an injection of 25mg of PGF(2α), and received TAI concomitantly with an injection of 100 µg of GnRH 53 to 60 h later. Heifers were observed for estrus and inseminated up to 98 and 73 d after enrollment in sites A and B, respectively. Thereafter, heifers were moved to pens with bulls and considered failure to conceive to AI if still not pregnant at the end of the observation period. Economic outcomes were based on cost of synchronization protocol (CIDR treatment=$11, PGF(2α) or GnRH treatments=$2.5/treatment, estrous detection=$0.80/heifer per day), rearing cost ($2.75/heifer per day), and economic loss if a heifer did not conceive to first AI ($150). Input cost of the reproductive programs=synchronization protocol cost + semen cost + rearing cost + replacement cost. Pregnancy per AI (P/AI) 38 ± 3 d after first AI was greatest for AIE heifers (61.1%) followed by CIDR5 (44.8%) and CIDR7 (35.7%) heifers. Furthermore, P/AI 73 ± 7 d after first AI was greatest for AIE (58.8%) and tended to be greater for CIDR5 (42%) than for CIDR7 (34.1%) heifers. The percentage of heifers that had spontaneous luteolysis from CIDR insertion to CIDR removal was reduced for CIDR5 compared with CIDR7 (13.8 vs 31.8%). Pregnancy rate was greatest for AIE heifers but did not differ between CIDR5 [adjusted hazard ratio (95% confidence interval)=0.75 (0.63, 0.90)] and CIDR7 [adjusted hazard ratio (95% confidence interval)=0.65 (0.54, 0.77)] heifers. Consequently, rearing cost and input cost of AIE heifers ($67.1 ± 4.4 and -$107.1 ± 7.0, respectively) were reduced compared with CIDR5 ($86.9 ± 5.1 and -$143.4 ± 8.1, respectively) and CIDR7 ($98.3 ± 5.1 and -$156.5 ± 8.2, respectively) heifers, but no differences were observed between CIDR5 and CIDR7 heifers.
Assuntos
Indústria de Laticínios/métodos , Dinoprosta/farmacologia , Sincronização do Estro/métodos , Animais , Bovinos , Indústria de Laticínios/economia , Dinoprosta/efeitos adversos , Detecção do Estro/métodos , Feminino , Inseminação Artificial/economia , Inseminação Artificial/métodos , Inseminação Artificial/veterinária , Gravidez , Fatores de TempoRESUMO
The objectives of the current experiment were to determine the effect of 2 prepartum grouping strategies on the health, metabolic, reproductive, and productive parameters of dairy cows. Jersey cows enrolled in the experiment at 253±3 d of gestation (d 0=calving) were balanced for parity and projected 305-d mature equivalent and assigned to 1 of 2 treatments. Cows assigned to the traditional (TRD; n=6 replicates with a total of 308 cows) treatment were moved to the study pen as a group of 44 cows and weekly thereafter groups of 2 to 15 cows were moved to the study pen to reestablish stocking density. Cows assigned to the all-in-all-out (AIAO; n=6 replicates with a total of 259 cows) treatment were moved to the study pen in groups of 44 cows, but no new cows entered the AIAO pen until the end of the replicate. At the end of each replicate, a new TRD and AIAO group started but pens were switched. Cows were milked thrice daily and monthly milk yield, fat and protein contents, and somatic cell count data were recorded up to 305 d postpartum. Plasma nonesterified fatty acid concentration was measured weekly from d -18±3 to 24±3 and plasma ß-hydroxybutyrate was measured weekly from d 3±3 to 24±3. Cows were examined on d 1, 4±1, 7±1, 10±1, and 13±1 for diagnosis of uterine diseases and had their ovaries scanned by ultrasound on d 39±3 and 53±3 to determine resumption of ovarian cycles. Average stocking density was reduced for the AIAO (71.9%) treatment compared with the TRD (86.9%) treatment. Treatment did not affect the incidences of retained fetal membranes (TRD=10.9, AIAO=11.6%), metritis (TRD=16.7, AIAO=19.8%), and acute metritis (TRD=1.7, AIAO=3.6%). Concentrations of nonesterified fatty acids (TRD=80.4±8.2, AIAO=62.9±8.5 µmol/L) and ß-hydroxybutyrate (TRD=454.4±10.9, AIAO=446.1±11.1 µmol/L) were not different between treatments. Percentages of cows that resumed ovarian cycles by d 39±3 (TRD=70.8, AIAO=63.1%) and 53±3 (TRD=90.1, AIAO=90.2%) were not different between treatments. Similarly, treatment had no effect on rate of removal from the herd {TRD=referent, AIAO [(adjusted hazard ratio (95% confidence interval)]=0.85 (0.63, 1.15)} or rate of pregnancy [TRD=referent, AIAO=1.07 (0.88, 1.30)]. Finally, treatment did not affect energy-corrected milk yield (TRD=34.4±0.6, AIAO=34.3±0.7 kg/d). In conditions of adequate feed bunk space, the AIAO treatment did not improve health, metabolic, reproductive, or productive parameters compared with the TRD treatment.
Assuntos
Comportamento Animal/fisiologia , Bovinos/fisiologia , Indústria de Laticínios/métodos , Nível de Saúde , Reprodução/fisiologia , Comportamento Social , Ácido 3-Hidroxibutírico/sangue , Fenômenos Fisiológicos da Nutrição Animal , Animais , Composição Corporal , Doenças dos Bovinos/epidemiologia , Contagem de Células , Gorduras/análise , Ácidos Graxos não Esterificados/sangue , Feminino , Idade Gestacional , Lactação , Leite/química , Leite/citologia , Proteínas do Leite/análise , Ovário/diagnóstico por imagem , Gravidez , Transtornos Puerperais/epidemiologia , Transtornos Puerperais/veterinária , UltrassonografiaRESUMO
Objectives were to evaluate the effects of a stable prepartum grouping strategy on innate immune parameters, antibody concentration, and cortisol and haptoglobin concentrations of Jersey cows. Cows (253±3 d of gestation) were paired by gestation length and assigned randomly to the stable (all-in-all-out; AIAO) or traditional (TRD) treatment. In the AIAO treatment, groups of 44 cows were moved into a pen where they remained for 5 wk, whereas in the TRD treatment, approximately 10 cows were moved into a pen weekly to maintain stocking density (44 cows for 48 headlocks). Pens were identical in size and design and each pen received each treatment a total of 3 times (6 replicates; AIAO, n=259; TRD, n=308). A subgroup of cows (n=34/treatment) was selected on wk 1 of each replicate from which blood was sampled weekly from d -14 to 14 (d 0=calving) to determine polymorphonuclear leukocyte (PMNL) phagocytosis, oxidative burst, and expression of CD18 and L-selectin, hemogram, cortisol and glucose concentrations, and haptoglobin concentration. Another subgroup of cows (n=40/treatment) selected on wk 1 of each replicate was treated with chicken egg ovalbumin on d -21, -7, and 7 and had blood sampled weekly from d -21 to 21 for determination of immunoglobulin G anti-ovalbumin. All cows (n=149) had blood sampled weekly for nonesterified fatty acid (NEFA) and ß-hydroxybutyrate (BHBA) concentrations from d -21 to 21. Treatment did not affect percentage of PMNL positive for phagocytosis and oxidative burst (AIAO=64.3±2.9 vs. TRD=64.3±2.9%) and intensity of phagocytosis [AIAO=2,910.82±405.99 vs. TRD=2,981.52±406.87 geometric mean fluorescence intensity (GMFI)] and oxidative burst (AIAO=7,667.99±678.29 vs. TRD=7,742.70±682.91 GMFI). Similarly, treatment did not affect the percentage of PMNL expressing CD18 (AIAO=96.3±0.7 vs. TRD=97.8±0.7%) and L-selectin (AIAO=44.1±2.8 vs. TRD=45.1±2.8%) or the intensity of expression of CD18 (AIAO=3,496.2±396.5 vs. TRD=3,598.5±396.9 GMFI) and L-selectin (AIAO=949.8±22.0 vs. TRD=940.4±22.3 GMFI). Concentration of immunoglobulin G anti-ovalbumin was not affected by treatment (AIAO=0.98±0.05 vs. TRD=0.98±0.05 OD). The percentage of leukocytes classified as granulocyte (AIAO=38.9±1.5 vs. TRD 38.2±1.5%) and the granulocyte:lymphocyte ratio (AIAO=0.75±0.04 vs. TRD=0.75±0.04) were not affected by treatment. Concentrations of cortisol (AIAO=14.95±1.73 vs. TRD=18.07±1.73 ng/mL), glucose (AIAO=57.6±1.5 vs. TRD=60.0±1.5 ng/mL), and haptoglobin (AIAO=3.09±0.48 vs. TRD=3.51±0.49 OD) were not affected by treatment. According to the current experiment, a stable prepartum grouping strategy does not improve innate immune parameters or antibody concentration compared with weekly prepartum regrouping.
Assuntos
Ácido 3-Hidroxibutírico , Imunidade Inata , Ácido 3-Hidroxibutírico/sangue , Animais , Anticorpos , Bovinos , Ácidos Graxos não Esterificados/sangue , Feminino , Selectina L , LactaçãoRESUMO
B-cell acute lymphocytic leukemia (B-ALL) is the main neoplasia affecting children worldwide, in which cytotoxic chemotherapy remains the main treatment modality. In this study, we analyzed the profile of inflammatory markers concerning oxidative stress and cytokines in 17 B-ALL patients. Peripheral blood (PB) and bone marrow (BM) samples were collected and evaluated for the pro-oxidative status (nitric oxide products-NOx and hydroperoxides), antioxidants (sulfhydryl groups-SH and total radical-trapping antioxidant parameter-TRAP), and cytokines (TNF-α, IFN-γ), at diagnosis (D0) to and the end of the induction phase (D28). At D28, hydroperoxides were higher in PB, concomitant to TNF-α levels. INF-γ was increased in the BM at D28. Hydroperoxides were higher in patients presenting malignant cells in BM and/or PB after treatment, a condition named minimal residual disease (MRD) when compared to those without MRD at D28. These findings suggest that oxidative stress and cytokines vary across the B-ALL induction phase, and lipid peroxidation is a potential marker associated with MRD status.
RESUMO
Objectives were to evaluate the effects of prepartum stocking density on innate and adaptive leukocyte responses, serum cortisol and haptoglobin concentrations and hair cortisol concentration of Jersey cows. The cows (254 ± 3d of gestation) were balanced for parity (nulliparous vs. parous) and previous lactation projected 305-d mature equivalent milk yield and assigned to one of two treatments: 80SD=80% stocking density (38 animals/48 headlocks) and 100SD=100% stocking density (48 animals/48 headlocks). Pens (n=4) were identical in size and design and each pen received each treatment a total of 2 times (4 replicates; 80SD: n=338; 100SD: n=418). A sub-group of cows (n=48/treatment per parity) was randomly selected on week 1 of each replicate from which blood was sampled weekly from d -14 to 14 (d 0=calving) to determine polymorphonuclear leukocyte (PMNL) phagocytosis, oxidative burst, and expression of CD18 and L-selectin, and hemogram. The same sub-group of cows was treated with chicken egg ovalbumin on d -21, -7, and 7 and had blood sampled weekly from d -21 to 21 for determination of serum IgG anti-ovalbumin concentration. Blood was sampled weekly from d -21 to 21 to determine glucose, cortisol, and haptoglobin concentrations in serum. Hair samples collected at enrollment and within 24h of calving were analyzed for cortisol concentration. The percentage of leukocytes classified as granulocyte and the granulocyte to the lymphocyte ratio were not affected by treatment. Treatment did not affect the percentage of PMNL positive for phagocytosis and oxidative burst or the intensity of phagocytosis and oxidative burst. Similarly, treatment did not affect the percentage of PMNL expressing CD18 and L-selectin or the intensity of expression of CD18 and L-selectin. Concentration of IgG anti-ovalbumin was not affected by treatment. Serum concentrations of haptoglobin and cortisol were not affected by treatment. Similarly, hair cortisol concentration at calving was not affected by treatment. According to the current experiment, a target stocking density of 80% did not improve leukocyte responses compared with 100% target stocking density.
Assuntos
Bovinos/fisiologia , Aglomeração , Abrigo para Animais , Hidrocortisona/sangue , Leucócitos/fisiologia , Animais , Bovinos/imunologia , Indústria de Laticínios , Feminino , Cabelo/química , Haptoglobinas/metabolismo , Gravidez , Explosão Respiratória , Estresse FisiológicoRESUMO
Este estudio epidemiológico tuvo el propósito de verificar la frecuencia de los hábitos bucales de succión en la dentadura temporal y de los diferentes tipos de maloclusiones causados por ella. La muestra estuvo compuesta por 2.016 niños de 8 escuelas particulares y 12 escuelas públicas del municipio de BauruSP (Brasil), de los cuales 1.032 fueron varones y 984 mujeres, en fase de dentadura temporal completa. La franja de edad fue la comprendida entre los 3 y los 6 años de edad. Los hábitos bucales de succión estuvieron presentes en 48,86 por ciento de los niños, siendo más frecuentes en las niñas (54,37 por ciento) y en las escuelas públicas (54 por ciento). Los niños demostraron menor dependencia de hábitos bucales de succión con el aumento de la edad. En relación a las formas en que los hábitos se manifiestan, las más frecuentes fueron el biberón (29,96 por ciento), el chupete (28,95 por ciento), seguidos por la asociación de hábitos (20,68 por ciento), dedo (9,72 por ciento) y labio (0,89 por ciento). De las maloclusiones asociadas a los hábitos, la más frecuente fue la mordida abierta anterior (50,76 por ciento), seguida por la mordida cruzada posterior (18,88 por ciento) y por la asociación entre mordida abierta anterior y mordida cruzada posterior (10,35 por ciento). Aproximadamente, el 20 por ciento de los niños con hábitos bucales de succión no exibieron maloclusión con etiología vinculada a la presencia de éstos. No fue observado ningún vínculo etiológico entre hábitos bucales de succión y relación dentaria de clase II de Angle (AU)